JFL Life Sciences Limited (NSE:JFLLIFE)

JFL Life Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	8.16	14.62	0.64	4.41	0.6	1.9
Cash & Short-Term Investments	8.16	14.62	0.64	4.41	0.6	1.9
Cash Growth	-62.78%	2188.11%	-85.51%	635.17%	-68.42%	375.00%
Accounts Receivable	903.67	532.61	349.45	258.47	224.6	198.1
Other Receivables	-	0.25	0.02	0.27	0.3	0.9
Receivables	903.67	532.85	349.47	258.74	224.9	199
Inventory	336.67	345.48	232.41	158.33	127.2	149.6
Prepaid Expenses	-	-	-	-	-	0.1
Other Current Assets	103.61	22.05	12.52	14.54	58.6	42.3
Total Current Assets	1,352	915	595.04	436.02	411.3	392.9
Property, Plant & Equipment	139.01	145.4	122.36	124.74	68	71.3
Long-Term Deferred Tax Assets	-	-	-	1.22	-	-
Other Long-Term Assets	2.07	2.06	1.74	5.12	11.3	18.4
Total Assets	1,493	1,062	719.14	567.1	490.6	482.6

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	640.67	292.83	177.57	125.14	73.9	154.4
Accrued Expenses	-	3.34	3.61	0.8	3.1	1.2
Short-Term Debt	118.49	148.47	102.1	52.9	57.9	53.8
Current Portion of Long-Term Debt	-	-	-	-	-	20.6
Current Income Taxes Payable	60.62	42.99	21.82	16.78	9.8	10.6
Current Unearned Revenue	28.72	-	-	10.15	-	-
Other Current Liabilities	29.45	42.26	11.11	0.5	7.5	43.2
Total Current Liabilities	877.94	529.88	316.22	206.28	152.2	283.8
Long-Term Debt	98.03	68.82	3.8	4.02	13.9	84.1
Pension & Post-Retirement Benefits	-	1.39	1.3	1.04	-	-
Long-Term Deferred Tax Liabilities	3.74	3.67	3.27	-	1.8	1.8
Total Liabilities	981.02	603.77	324.59	211.35	167.9	369.7

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	329.95	329.95	329.95	109.98	110	80.2
Additional Paid-In Capital	-	-	-	156.47	156.5	4.6
Retained Earnings	-	128.74	64.6	89.3	56.2	28.1
Shareholders' Equity	512.17	458.69	394.55	355.75	322.7	112.9
Total Liabilities & Equity	1,493	1,062	719.14	567.1	490.6	482.6

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	216.52	217.29	105.9	56.92	71.8	158.5
Net Cash (Debt)	-208.36	-202.67	-105.26	-52.51	-71.2	-156.6
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.33	-6.14	-3.19	-1.59	-2.45	-7.66
Filing Date Shares Outstanding	33.03	33	33	33	33	24.06
Total Common Shares Outstanding	33.03	33	33	33	33	24.06
Working Capital	474.17	385.12	278.83	229.74	259.1	109.1
Book Value Per Share	15.51	13.90	11.96	10.78	9.78	4.69
Tangible Book Value	512.17	458.69	394.55	355.75	322.7	112.9
Tangible Book Value Per Share	15.51	13.90	11.96	10.78	9.78	4.69
Land	-	-	-	-	28.5	28.5
Buildings	-	44.28	43.87	43.87	4.7	4.8
Machinery	-	99.31	65.94	58.39	56	55

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error